Publications by authors named "Beth M Forster"

Claim this Profile
B
Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models.
Michael P Johnson, Mark A Muhlhauser, Eric S Nisenbaum, Rosa M A Simmons, Beth M Forster

Br J Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
Linda M Rorick-Kehn, Jeffrey M Witkin, Michael A Statnick, Elizabeth L Eberle, Jamie H McKinzie, Beth M Forster

Neuropharmacology· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
Ronald B Demattos, Jirong Lu, Ying Tang, Margaret M Racke, Cindy A Delong, Beth M Forster

Neuron· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis